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cell lung cancers (NSCLCs). The present study, a prospective trial 
built on our experience with PLC in patients undergoing resection for 
NSCLCs and followed for long-term outcome, was undertaken to ana-
lyze survival and pattern of recurrence with particular reference to PLC 
ﬁndings with early stage diseases.
Methods: From January 1991 to December 2003, PLC was performed 
before any manipulation or resection of the lung for 915 consecutive 
patients who had no macroscopic pleural effusion, dissemination or 
diffuse adhesions and who subsequently underwent curative resection 
for NSCLCs. Results of PLC with reference to clinical and pathologic 
characteristics (gender, age, tumor location, histology, postoperative 
stage, T category, N category and p status), adjuvant therapy, 5-year 
survival and recurrence patterns were analyzed. Cancer recurrence was 
divided into three categories according to the sites of initial recurrence: 
loco-regional, pleural and distant. Pleural recurrence was deﬁned as 
any recurrent disease within the hemithoracic pleura.
Results: There were 367 women and 548 men, with a mean age of 
62.8 years (range, 16 to 86 years). The ﬁndings of cytologic examina-
tion were not inﬂuenced by age (P=0.80). Among the total, 43 (4.7%) 
had positive PLC ﬁndings: 26(4.7%) males and 17 (4.6%) females. 
Positive results were obtained much more frequently in patients with 
adenosquamous carcinoma (13%) or adenocarcinomas (5.6%) and 
were lacking with squamous cell carcinomas and large cell carcinomas. 
The overall 5-year survival rate was 41% in patients with positive 
PLC ﬁndings and 74% in patients with negative results, the difference 
being statistically signiﬁcant (P=0.001). The 5-year survival rates of 
patients with stage I disease with negative and positive cytologic ﬁnd-
ings were 85% and 56% respectively, again with statistical signiﬁcance 
(P=0.001). In the positive PLC group, distant metastases (69%) and 
pleural recurrence (28%; P<0.0001) were often observed, even for 
patients with stage I diseases (P<0.001). As adjuvant therapies in 
the positive group, six patients had hypotonic cisplatin and 18 had 
distilled water infusion into the pleural space after lung resection. The 
5-year survival rates for the two positive PLC groups with and without 
adjuvant therapy were 38% and 45% respectively, the difference be-
ing statistically not signiﬁcant (P=0.16). Although only three patients 
suffered from pleural recurrence, these therapies did not improve long-
term outcome. 
Conclusions: Although the numbers of patients with positive PLC 
results were limited, as in many other studies on this topic, our 
results conﬁrm that PLC is a distinct prognostic factor for early-stage 
NSCLCs. Thus, we suggest that cytologic examination of intra-opera-
tive PLC should be performed routinely even for patients with stage I 
NSCLCs before beginning lung resection. Moreover, curative resection 
followed by any adjuvant systemic therapies could be necessary for 
improvement of outcome for PLC positive patients.
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Background: To summarize the results of extended resection of the 
heart, great vessels, or both in the treatment of 349 patients with locally 
advanced lung cancer. 
Methods: From February 1983 to December 2004, lobectomy or 
pneumonectomy combined with extended resection of the heart, great 
cessels or both were carried out in 1049 patients with locally advanced 
lung cancer. The operations included bronchoplastic procedures and 
pulmonary artery reconstruction in 725 cases, extended resection of left 
atrium in 145 cases, superior vena cava resection and reconstruction in 
175 cases (21 patients had carina resection and reconstruction simulta-
neously), and aorta resection and reconstruction in 4 cases respectively. 
Results: There were 10 operative death. The operative mortality was 
0.95% in the series. Ninty-three patients had operative complications. 
The 1,3,5 and 10-year survival rates were 74.36%, 51.93%,32.14% and 
22.56% respectively. 
Conclusion: Selectively extended resection of the heart, great vessels 
or both can remarkably increase the long-term survival and improve the 
prognosis in patient with locally advanced non-small cell lung cancer. 
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Background: QOL is a multidimensional phenomenon that can be 
inﬂuenced by the experience of living with lung cancer. Disruptions 
in QOL are important to monitor during the entire continuum of the 
disease, from diagnosis to treatment, during recovery and rehabilita-
tion. Although QOL data frequently are obtained in clinical trials for 
advanced lung cancer, information is limited about QOL after the initial 
diagnosis and treatment when individuals continue to live and are faced 
with the possibility of recurrence and metastasis. Furthermore it is 
unknown if QOL can be inﬂuenced by follow-up and rehabilitation.
Material: 145 patients (86 men, 59 women) were included in this study 
after radical surgery for non-small cell lung cancer. Type of resection 
included lobectomy (n=99), pneumonectomy (n=32) and segment/sub-
segment resection (n=14). The remaining patients were referred to 
oncological treatment and excluded from the study. Only patients who re-
sponded to the preoperative and at least one postoperative Quality of Life 
questionnaire EORTC QLQ-C30 are included in this preliminary report.
Methods: All patients underwent standard surgical resection with a 
posterolateral thoracotomy. Adjuvant chemotherapy was offered to all 
stages except 1a. After radical surgery, patients were offered participa-
tion in the study and randomized to either intensive follow-up and reha-
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bilitation (group 1) or standard care (group 2). Postoperative follow up 
and rehabilitation in group 1 included clinical evaluation, chest X-ray, 
CT of thorax, bronchoscopy, and EBUS (Endobronchial Ultrasound) 
each year the following 5 years. Furthermore, the patients in group 1 
consulted a nurse and a physiotherapist, 6 weeks and 6 months after 
surgery. Patients in group 2 were only offered chest X-ray one year 
after surgery and a clinical examination by their community doctors, if 
they experienced any symptoms. 
Quality of life in both groups was assessed after 6 weeks, 6 months, 
12 months and 2 years by a standardized QOL-questionnaire (EORTC 
QLQ-C30). The 15 different scales in the QOL-questionnaire evaluate 
both functional status and symptoms.
Results: We found a signiﬁcant improvement of role functioning in 
favour of intensive follow-up and rehabilitation (p<0.01) There was 
also a signiﬁcant reduction of pain (p<0.01), fatigue (p<0.01), and loss 
of appetite (p<0.02) in this group.
Overall there was a tendency toward fewer symptoms and better func-
tional status in group 1 with intensive clinical follow-up and rehabilita-
tion compared to group 2.
Conclusion: The preliminary results of this randomized trial indicate 
that intensive follow-up and rehabilitation programmes for patients 
operated for non-small cell lung cancer increases functional status and 
reduces postoperative symptoms.
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Background: Accurate intraoperative diagnosis of lymph node metas-
tasis for patients with non-small cell lung cancer may facilitate decision 
of the extent of lymph node dissection at the time of surgery. The 
aim of this retrospective study was to deﬁne the accuracy of intraopera-
tive diagnosis of lymph node metastasis.
Methods: During the 14-year period between 1993 and 2006, 420 pa-
tients who underwent complete resection and mediastinal lymph node 
dissection for non-small cell lung cancer were reviewed in this study. 
Intraoperative diagnosis was made by individual surgeons using lymph 
node manipulation and/or frozen pathological examination.
Results: Of 420 patients, 
274 were men and 146 were 
women. Postoerative histologi-
cal diagnosis was as follows: 
adenocarcinoma, 259; squa-
mous cell carcinoma, 123; large 
cell carcinoma, 26; the other 
histological type, 11. Surgi-
cal diagnosis of lymph node 
metastasis was as follows: sN0, 
289; sN1, 50; sN2, 69; sN3, 12. 
Pathological diagnosis of lymph node metastasis was as follows: pN0, 
255; pN1, 56; pN2, 96; pN3, 13. The relationship between surgical 
(intraoperative) diagnosis and ﬁnal pathological diagnosis is shown in 
table. Of 289 patients who were recognized to have no lymph node me-
tastasis (sN0) during surgery, 28 (10%) patients had mediastinal lymph 
node metastasis (pN2) pathologically. Of 50 who were recognized to 
have hiler lymph node metastasis (sN1), 16 (32%) had mediastinal 
lymph node metastasis (pN2) pathologically. Whereas of 69 patients 
who were recognized to have mediastinal lymph node metastasis, 12 
(17%) patients had no lymph node metastasis (pN0). 
Conclusions: Surgical diagnosis for lymph node metastasis was inac-
curate. Systematic lymphadenectomy was recommended regardless of 
intraoperative diagnosis.
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Background: We evaluated the radiologic, pathologic and biologi-
cal aspects of lung cancers 3cm or smaller in diameter to predict their 
oncological behaviors.
Materials and Methods: We retrospectively reviewed CT, PET and 
pathology reports of 135 lung cancers smaller than 3cm among 302 
surgically resected lung cancers from June 2003 to May 2006. The 
ground-glass opacity(GGO) component of the tumor on HRCT, stan-
dardized uptake value(SUV) on FDG-PET, serum CEA, histopatho-
logic features and a panel of immunohistochemical stains including 
Glut-1, Ki-67, p16, p27 were evaluated.
Results: On HRCT, 32(23.7%) patients had GGO component; 14 were 
pure GGO and 18 were mixed GGO. Forty seven(34.8%) patients had 
lymph node metastasis; N1 in 28 cases, N2 in 19 cases. All N2 patients 
showed solid lesion except one mixed GGO with solid component 
more than 90%. During follow up period(mean=21months), all the 
recurred cases (n=15) had pure solid lesion. The maxSUV was a pre-
dictor of recurrence (p=0.03). The maxSUV of tumor was signiﬁcantly 
increased in soli d lesions (4.74) comparing pure(1.78) and mixed 
(1.41) GGO lesions. The maxSUV is signiﬁcantly low er in N0 tumors 
than N1 or N2 cases(p=0.04). The max SUV was also signiﬁcantly 
lower in BAC than in squamous cell carcinoma or large cell carcinoma 
(2.2 vs 5.7 or 8.8, p=0.04). Tumors with high maxSUV showed Glut-1 
and Ki-67 over-expression indicating increased cell proliferation. In 
contrast, tumors with GGO showed signiﬁcantly low maxSUV, low 
Glut-1 and Ki-67 expression and relatively maintained p16, p27 protein 
expression(p<0.05). Serum CEA level is higher in solid tumors(3.18ng/
ml vs 1.9 in GGO) and N2 lesions(5.07ng/ml vs 2.32 in N0 or 3.02 in 
N1, p=0.01), but had no correlation with recurrence. 
Conclusions: Showing good correlation with histopathologic panels 
and recurrence, GGO components and SUV could effectively utilized 
for the expectation of oncologic behaviors of the tumors and individu-
alized adjuvant therapy. 
